Press Releases

EXTON, Pa. , Oct. 8, 2020 /PRNewswire/ --   West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will release third-quarter 2020 financial results before the market opens on Thursday, October 22, 2020 ,

- Conference Call Scheduled for 9 a.m. EDT Today - EXTON, Pa. , July 23, 2020 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the second-quarter 2020 and updated full-year 2020 financial guidance.

EXTON, Pa. , July 15, 2020 /PRNewswire/ --   West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, announced today that the Company's Board of Directors has approved a third-quarter 2020 dividend of $0.16 per share.  The dividend

EXTON, Pa. , July 9, 2020 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will release second-quarter 2020 financial results before the market opens on Thursday, July 23, 2020 , and

EXTON, Pa. , May 21, 2020 /PRNewswire/ --  West Pharmaceutical Services, Inc.  (NYSE: WST), a global leader in innovative solutions for injectable drug administration, announced that it has been named to the S&P ® 500, which will become effective after close of trading today.  "We are honored to be

EXTON, Pa. , May 7, 2020 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced it will participate in the Bank of America Securities 2020 Healthcare Conference on Thursday, May 14, 2020 , as well

Key donations made to the World Health Organization COVID-19 Solidarity Response Fund, American Red Cross, American Nurses Foundation, No Kid Hungry and Philabundance Exton, PA — April 28, 2020 — Building on a strong culture of giving back to the communities where team members live and work, West

- Conference Call Scheduled for 9 a.m. EDT Today - EXTON, Pa. , April 23, 2020 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the first-quarter 2020 and updated full-year 2020 financial guidance.

EXTON, Pa. , April 20, 2020 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it is in the best interests of shareholders to hold a virtual shareholder meeting due to the ongoing COVID-19

EXTON, Pa. , April 9, 2020 /PRNewswire/ --   West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will release first-quarter 2020 financial results before the market opens on Thursday, April 23, 2020 ,

EXTON, Pa. , Feb. 25, 2020 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, announced today that the Company's Board of Directors has approved a second-quarter 2020 dividend of $0.16 per share.

EXTON, Pa. , Feb. 17, 2020 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced the Company's Board of Directors has elected Robert Friel as its newest member. With the addition of Mr.

- Conference Call Scheduled for 9 a.m. EST Today - EXTON, Pa. , Feb. 13, 2020 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the fourth-quarter and full-year 2019 and introduced full-year 2020 financial guidance.

AccelTRA® Component Line Extensions, New Container Closure System and Ready Pack™ System Featuring SCHOTT iQ® Platform Bring Greater Value to Global Customers, Advance West Industry Leadership EXTON, Pa. , Feb. 5, 2020 /PRNewswire/ -- (Booth #B58) West Pharmaceutical Services, Inc.

EXTON, Pa. , Jan. 30, 2020 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will release fourth-quarter and full-year 2019 financial results before the market opens on Thursday,

EXTON, Pa. , Jan. 28, 2020 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, was recently named as a Top Company for Corporate Responsibility practices by both Newsweek and Investor's Business Daily .

EXTON, Pa. , Dec. 13, 2019 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, announced today that the Company's Board of Directors has approved a first-quarter 2020 dividend of $0.16 per share.

EXTON, Pa. , Nov. 19, 2019 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that management will present an overview of the business at the Jefferies 2019 London Healthcare Conference in

Supports Global Customers Seeking High-quality, Ready-to-use Packaging Products FRANKFURT, Germany , Nov. 6, 2019 /PRNewswire/ --  (Booths #F62 & #F10 -Hall 11.1 )   West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, and the

Advanced Elastomer Formulation and AccelTRA® Line Extension Components Expand Company's Drug Containment and Delivery Portfolio; West Marks First Anniversary of Integrated Solutions Program EXTON, Pa. , Nov. 5, 2019 /PRNewswire/ -- (Booth #111F62)— West Pharmaceutical Services, Inc.

- Conference Call Scheduled for 9 a.m. EDT Today - EXTON, Pa. , Oct. 24, 2019 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the third-quarter 2019 and updated full-year 2019 financial guidance.

Scientific Presentations & Trainings Highlight Scientific Leadership in Drug Containment & Delivery EXTON, Pa. , Oct. 22, 2019 /PRNewswire/ --  (Booths #F44 & #F51)— West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today

EXTON, Pa. , Oct. 16, 2019 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration and delivery, today announced that it has increased its minority equity stake to 49 percent in Daikyo Seiko, Ltd.

  EXTON, Pa. , Oct. 10, 2019 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will release third-quarter 2019 financial results before the market opens on Thursday, October 24, 2019 ,

EXTON, Pa. , Aug. 23, 2019 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that management will present an overview of the business at two investor conferences in September.

- Conference Call Scheduled for 9 a.m. EDT Today - EXTON, Pa. , July 25, 2019 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the second-quarter 2019 and updated full-year 2019 financial guidance.

EXTON, Pa., July 11, 2019 /PRNewswire/ --   West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will release second-quarter 2019  financial results before the market opens on Thursday, July 25, 2019 ,

Company Announces New AccelTRA® Component Program Product Extension, Showcases Industry Thought Leadership at Conference EXTON, Pa. , May 22, 2019 /PRNewswire/ --  West Pharmaceutical Services , Inc.  (NYSE: WST), a global leader in innovative solutions for injectable drug administration, is

EXTON, Pa. , May 8, 2019 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, announced today that the Company's Board of Directors has approved a third-quarter 2019 dividend of $0.15 per share.

- Conference Call Scheduled for 9 a.m. EDT Today - EXTON, Pa. , April 25, 2019 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the first-quarter 2019 and updated full-year 2019 financial guidance.

EXTON, Pa. , April 12, 2019 /PRNewswire/ --  West Pharmaceutical Services, Inc.  (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced the Company's recognition by the Philadelphia Business Journal as a 2019 Faces of Philanthropy award recipient.

EXTON, Pa. , April 11, 2019 /PRNewswire/ --   West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will release first-quarter 2019  financial results before the market opens on Thursday, April 25, 2019 ,

SEOUL, South Korea , April 3, 2019 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced it has expanded its presence in the Asia Pacific region with a new sales office in Korea—West

BENGALURU, India , March 8, 2019 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today officially opened the Company's new Digital Technology Center (DTC) in Bengaluru, India , a regional hub of digital and

EXTON, Pa. , Feb. 21, 2019 /PRNewswire/ --  West Pharmaceutical Services, Inc.  (NYSE: WST) today announced that the Company's Board of Directors has approved a second-quarter 2019 dividend of $0.15 per share. The dividend will be paid on May 1, 2019 , to shareholders of record as of April 17, 2019

- Conference Call Scheduled for 9 a.m. EST Today - EXTON, Pa. , Feb. 14, 2019 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the fourth-quarter and full-year 2018 and provided financial guidance for full-year 2019.  Executive Summary

EXTON, Pa. , Jan. 31, 2019 /PRNewswire/ --   West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will release fourth-quarter and full-year 2018 financial results before the market opens on Thursday,

EXTON, Pa. , Dec. 18, 2018 /PRNewswire/ --  West Pharmaceutical Services, Inc.  (NYSE: WST) today announced that the Company's Board of Directors has approved a first-quarter 2019 dividend of $0.15 per share. The dividend will be paid on February 6, 2019 , to shareholders of record as of January

EXTON, Pa. , Nov. 1, 2018 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that its Management Team will present an overview of the Company's business at two investor conferences in November.

- Conference Call Scheduled for 9 a.m. EDT Today - EXTON, Pa. , Oct. 25, 2018 /PRNewswire/ --  West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the third-quarter 2018 and reaffirmed net sales and adjusted-diluted EPS guidance for full-year 2018.  Executive